Related Experiment Video
Updated: Jul 17, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment
N V Naoumov1, M G Thomas, A L Mason
1Institute of Liver Studies, King's College School of Medicine and Dentistry, London, England.
Background/Aims:
Interferon treatment causes a sustained loss of virus replication only in a proportion of patients with chronic hepatitis B. This study investigated whether genomic variations in the precore/core gene of hepatitis B virus affect the response to interferon alfa.
Methods:
The precore/core region was sequenced in 46 serum samples obtained before, during, and after interferon treatment of 12 patients.
Results:
In 23 samples from 7 responders (group A), there were 24 missense mutations, whereas in 23 samples from 5 patients who did not respond or relapsed after treatment (group B), there were 141 missense mutations (P < 0.001). All group B patients had cirrhosis, but only 2 of 7 patients in group A had cirrhosis (P = 0.026). Substitutions in amino acids 21-27 of the core protein, known to diminish HLA-A2-restricted cytotoxic T-cell function, were found in all nonresponders but in none of the responders. No significant changes occurred in the precore/core region in responders after seroconversion to antibody to hepatitis B e antigen, but multiple variations persisted in group B during treatment and new mutations appeared with the relapse of hepatitis.
Conclusions:
Specific mutations in the core protein that can interfere with T-cell function occur frequently in patients with advanced chronic hepatitis B and may affect the response to interferon.
More Related Videos
Related Concept Videos
Hepatic Drug Excretion: Influencing Factors
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

